BeiGene Ltd (BGNE)
138.99
+8.05
(+6.15%)
USD |
NASDAQ |
Apr 23, 16:00
139.02
+0.03
(+0.02%)
After-Hours: 20:00
BeiGene Cash from Operations (TTM): -1.157B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.157B |
| September 30, 2023 | -1.254B |
| June 30, 2023 | -1.738B |
| March 31, 2023 | -1.824B |
| December 31, 2022 | -1.497B |
| September 30, 2022 | -1.686B |
| June 30, 2022 | -1.620B |
| March 31, 2022 | -1.660B |
| December 31, 2021 | -1.299B |
| September 30, 2021 | -1.123B |
| June 30, 2021 | -973.75M |
| March 31, 2021 | -816.42M |
| December 31, 2020 | -1.283B |
| September 30, 2020 | -1.218B |
| June 30, 2020 | -1.137B |
| March 31, 2020 | -920.24M |
| December 31, 2019 | -750.27M |
| Date | Value |
|---|---|
| September 30, 2019 | -676.98M |
| June 30, 2019 | -544.16M |
| March 31, 2019 | -615.19M |
| December 31, 2018 | -547.72M |
| September 30, 2018 | -260.07M |
| June 30, 2018 | -121.29M |
| March 31, 2018 | -56.04M |
| December 31, 2017 | 12.75M |
| September 30, 2017 | -107.14M |
| June 30, 2017 | -138.01M |
| March 31, 2017 | -105.38M |
| December 31, 2016 | -89.51M |
| September 30, 2016 | -80.14M |
| June 30, 2016 | -65.74M |
| March 31, 2016 | -55.97M |
| December 31, 2015 | -39.84M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.824B
Minimum
Mar 2023
-544.16M
Maximum
Jun 2019
-1.220B
Average
-1.218B
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| Theravance Biopharma Inc | -27.00M |
| LumiraDx Ltd | -129.71M |
| ASLAN Pharmaceuticals Ltd | -- |
| Zai Lab Ltd | -198.18M |
| Legend Biotech Corp | -393.28M |